K13 mutations and pfmdr1 copy number variation in Plasmodium falciparum malaria in Myanmar

<p><strong>Background</strong></p> Artemisinin-based combination therapy has been first-line treatment for falciparum malaria in Myanmar since 2005. The wide extent of artemisinin resistance in the Greater Mekong sub-region and the presence of mefloquine resistance at the Mya...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Win, AA, Imwong, M, Kyaw, MP, Woodrow, CJ, Chotivanich, K, Hanboonkunupakarn, B, Pukrittayakamee, S
Formatua: Journal article
Hizkuntza:English
Argitaratua: BioMed Central 2016